Zymeworks Inc (ZYME) — Institutional Holders Breakdown (Q2 2026)

ZYME ranks #2963 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ZYME is a top-conviction position for EcoR1 Capital, LLC — at 29.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Assenagon Asset Management S.A. has added to its ZYME position for two straight quarters, increasing it by $21.7M to reach $39.9M today.

ZYME is down 2.8% today, but institutions show net buying of $15.4M this quarter — a divergence between today's price move and the underlying institutional flow.

ZYME reported a net loss of $150.0M over the trailing twelve months.

• Not yet profitable — net loss of $150.0M over the trailing twelve months
• Revenue declined 69.8% year over year
• Net income declined year over year, from -$73.7M to -$150.0M
• Operating cash flow was negative, using $33.0M in cash
• Current ratio of 5.88x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.29x equity — within a conventional range